【レポートの概要（一部）】
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market, By Indication
5.1 Introduction
5.2 Breast Cancer
5.3 Colorectal Cancer
5.4 Lung Cancer
5.5 Others Indications
6 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market, By Blocking Drug
6.1 Introduction
6.2 Monoclonal Antibodies
6.2.1 Cetuximab
6.2.2 Necitumumab
6.3 Tyrosine Kinase Inhibitors (TKI)
6.3.1 Erlotinib
6.3.2 Gefitinib
7 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Amgen Inc
9.2 Bristol-Myers Squibb
9.3 Erbitux
9.4 F. Hoffmann-La Roche Ltd
9.5 Genentech, Inc
9.6 OSI Pharmaceuticals Inc
9.7 Tarceva
9.8 Vectibix
List of Tables
Table 1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 5 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 6 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 7 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 8 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 9 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 10 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 11 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 12 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 13 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 14 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 15 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 16 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 17 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 18 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 19 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 20 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 21 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 22 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 23 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 24 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 25 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 26 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 27 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 28 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 29 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 30 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 31 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 32 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 33 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 34 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 35 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 36 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 37 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 38 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 39 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 40 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 41 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 42 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 43 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 44 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 45 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 46 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 47 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 48 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 49 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 50 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 51 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 52 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 53 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 54 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 55 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 56 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 57 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 58 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 59 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 60 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 61 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 62 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 63 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 64 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 65 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 66 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 67 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 68 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 69 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 70 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 71 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 72 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 73 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 74 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 75 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 76 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 77 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 78 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
【レポート販売概要】
■ タイトル：上皮増殖因子受容体（EGFR）阻害薬の世界市場展望2017-2026■ 英文：Epidermal Growth Factor Receptor (EGFR) Inhibitors - Global Market Outlook (2017-2026)
■ 発行日：2019年6月
■ 調査会社：Stratistics MRC
■ 商品コード：SMRC90773
■ 調査対象地域：グローバル
- グラフ分析の世界市場予測：コンポーネント別、組織規模別、用途別、業種別The global graph analytics market size to grow at a CAGR of 34.0% during the forecast periodThe graph analytics market size is projected to grow from USD 584 million in 2019 to USD 2,522 million by 2024, at a Compound Annual Growth Rate (CAGR) of 34.0% during the forecast period. The graph analytics market is driven by the growing demand to analyze low-latency queries, advancements in graph analyt …
- Mari Petroleum Company Limited社の石油・ガス開発・生産動向及びコスト分析（2013年）Mari Petroleum Company Limited Oil & Gas Exploration and Production Operations and Cost Analysis - 2013 Summary Mari Petroleum Company Limited (MPCL) is an upstream oil and gas company. It carries out exploration and development of natural resources to produce crude oil, natural gas and condensates. The company holds interests in 14 blocks located in Pakistan and abroad, of which nine are self ope …
- 世界のタカフル保険市場動向（2014-2018）TechNavio’s analysts forecast the Global Takaful market will grow at a CAGR of 16.39 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing market opportunities. The Global Takaful market has also been witnessing the development of new technical expertise. However, low awareness levels could pose a challenge to the growth of this market. Tech …
- 医療レポート：Diabetic Neuropathy-疫学予測（～2022）EpiCast Report: Diabetic Neuropathy - Epidemiology Forecast to 2022 Summary Diabetic neuropathy affects an estimated 50% of patients with diabetes and is one of the leading causes of morbidity in diabetic patients, often leading to foot ulcerations or amputation. Diabetic neuropathy is clinically defined as “the presence of symptoms and/or signs of peripheral nerve dysfunction in people with diabe …
- 2,3-ジメチル-4-ニトロピリジンN-オキシドの世界市場2,3-Dimethyl-4-nitropyridine-N-oxide (CAS 37699-43-7) Market Research Report 2014 presents comprehensive data on 2,3-dimethyl-4-nitropyridine-n-oxide markets globally and regionally (Europe, Asia, North America etc.) The report includes 2,3-dimethyl-4-nitropyridine-n-oxide description, covers its application areas and related patterns. It overviews 2,3-dimethyl-4-nitropyridine-n-oxide market, name …
- 微生物学的検査/臨床微生物学の世界市場：実験室用計器、自動微生物検査装置、消耗品（検査キット・試薬）In this report, the global clinical microbiology market is segmented on the basis of products and applications. On the basis of products, the clinical microbiology market is segmented into consumables and instruments. Each of these market segments is further divided into multiple product segments and subsegments. The clinical microbiology consumables is further bifurcated into kits and reagents, w …
- 個人ケア分野プラスチックのグローバル市場動向2011-2016（Personal Care Plastics – A Global Market Watch, 2011 – 2016）Global Market Watch: The Personal Care Plastics market is expected to reach US$13.5 billion by 2016 primarily supported by the application sub sectors: Skin Care and Hair Care. Globally, Rigid and Flexible plastics together support the Personal Care plastics industry going forward. Geographical analysis shows that the highest Compounded Annual Growth Rate (CAGR) of 9.6% is anticipated from Asia-Pa …
- エチレン(ET)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world ethylene market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insight …
- 血管ステントの世界市場：冠動脈ステント、末梢血管ステントAbout the Vascular Stents Market A vascular stent is a mesh-like tube of thin wires developed using stainless steel or alloys. The device helps prevent arterial blockages that may occur in people who have undergone angioplasty. It helps maintain the patency of stenotic vessels and avoid re-blockage due to blood accumulation or excessive tissue growth. It also helps treat people with cardiovascular …
- グローバル調理食品市場におけるM&A動向（2014年3月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global prepared meals market during March 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global prepared meals market throughout the month. Additionally, the report provides an overview of all …
- 顕微鏡的多発血管炎(MPA)(Microscopic Polyangiitis)の治療薬パイプライン動向（2015年上半期版）Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2015’, provides an overview of the Microscopic Polyangiitis (MPA)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Microscopic Polyangiitis (MPA), complete with comparative analysis at various stage …
- 医療レポート：Psoriasis-疫学予測（～2022）EpiCast Report: Psoriasis - Epidemiology Forecast to 2022 Summary Psoriasis is an immune-mediated chronic disorder of the skin characterized by redness and irritation. It affects people of both sexes and of all ages and races/ethnicities. The global prevalence of psoriasis varies geographically, with the disease being more prevalent in the colder areas of the north, and less prevalent in the tropi …
- 油圧ユニットの世界市場The Hydraulic Power Unit (HPU) is an integrated package comprising hydraulic motor, hydraulic pump, and reservoir/accumulators along with other accessories such as valves, tubes, filter, regulators, and instruments to monitor the performance of a unit. It is used to transmit, control, and distribute energy from a pressurized fluid to perform various mechanical tasks. It is the main component of hy …
- 光学顕微鏡の世界市場：立体顕微鏡、倒立顕微鏡、顕微鏡付属品About Optical Microscope An optical microscope, commonly known as a light microscope, is a standard technical device used by scientists in life sciences as well as material sciences for magnifying images of small objects. It uses visible light and a combination of optical lenses like converging lenses and concave mirrors to produce an image of an object. Optical microscopes are the oldest type of …
- 移動ロボットの世界市場：無人陸上車両(UGV)、無人航空機(UAV)、無人艇(UMV)About Mobile Robotics A mobile robot is an automatic machine that is not fixed to one position. It is capable of moving in an environment for which it is designed. It can function autonomously or can be remotely controlled. Mobile robots have been deployed in the Aerospace and Defense industry for many years; however, now these robots are gaining popularity among industrial and commercial applicat …
